- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05117970
Artificial Intelligence-assisted Diagnosis and Prognostication in Low Ejection Fraction Using Electrocardiograms
February 3, 2023 updated by: Chin Lin, National Defense Medical Center, Taiwan
This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of left ventricular systolic dysfunction.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
84000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 114
- Recruiting
- National Defense Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with EF>50% or without Transesophageal Echocardiography (TEE)
Exclusion Criteria:
- Patients with a history of heart failure or an EF<= 35%.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SCREENING
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention
Patients randomized to intervention will have access to the screening tool.
|
Primary care clinicians in the intervention group had access to the report, which displayed whether the AI-ECG result was positive or negative.The system will send a message to corresponding physicians if positive finding.
|
NO_INTERVENTION: Control
Patients randomized to control will continue routine practice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
New Diagnosis of Low Ejection Fraction(defined as ejection fraction ≤35%)
Time Frame: Within 90 days
|
Ejection fraction obtained by echocardiography
|
Within 90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All cause mortality(death)
Time Frame: Within 365 days
|
After performing an electrocardiogram, the patient's survival is tracked.
|
Within 365 days
|
Cardiovascular cause mortality(death)
Time Frame: Within 365 days
|
After performing an electrocardiogram, the patient's survival is tracked.
|
Within 365 days
|
Transesophageal Echocardiography (TEE)
Time Frame: Within 90 days
|
After performing the ECG examination, perform theTransesophageal Echocardiography examination
|
Within 90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 9, 2021
Primary Completion (ANTICIPATED)
December 31, 2023
Study Completion (ANTICIPATED)
December 31, 2024
Study Registration Dates
First Submitted
November 1, 2021
First Submitted That Met QC Criteria
November 1, 2021
First Posted (ACTUAL)
November 11, 2021
Study Record Updates
Last Update Posted (ACTUAL)
February 8, 2023
Last Update Submitted That Met QC Criteria
February 3, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NDMC2021001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Left Ventricular Systolic Dysfunction (Disorder)
-
Mayo ClinicCompletedHeart Failure | Asymptomatic Left Ventricular Systolic Dysfunction (Disorder)United States
-
Seoul National University HospitalNot yet recruitingLeft Ventricular Systolic Dysfunction
-
Yale UniversityRecruiting
-
Newcastle-upon-Tyne Hospitals NHS TrustCompletedLeft Ventricular Function Systolic Dysfunction | Left Ventricular Function Diastolic Dysfunction | AgeingUnited Kingdom
-
Chang Gung Memorial HospitalCompletedLeft Ventricular Systolic DysfunctionTaiwan
-
Flinders UniversitySouth Australian Health and Medical Research InstituteActive, not recruitingHeart Failure | Left Ventricular Systolic DysfunctionAustralia, Germany, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingHeart Failure | Left Ventricular Systolic DysfunctionKorea, Republic of, United States, France, Finland, Portugal, Sweden, Denmark, Spain, Turkey, Hungary, Netherlands, Ireland, Malaysia, Colombia, Germany, Singapore, Thailand, Italy, New Zealand, Belgium, Brazil, Canada, United Kingdom
-
Royal Cornwall Hospitals TrustSuspendedHeart Failure | Cognitive Impairment | Cognitive Change | Heart Failure, Systolic | Left Ventricular Dysfunction | Systolic Heart Failure | Cognitive Impairment, Mild | Left Ventricular Systolic Dysfunction | Systolic DysfunctionUnited Kingdom
-
Berlin Heals GmbHRecruitingSystolic Left Ventricular DysfunctionCroatia, Serbia, Bosnia and Herzegovina
-
Berlin Heals GmbHRecruitingSystolic Left Ventricular DysfunctionSwitzerland, Croatia, Germany, Spain, Serbia, Bosnia and Herzegovina, Bulgaria, Greece, North Macedonia, Poland, Czechia
Clinical Trials on AI-enabled ECG-based Screening Tool
-
National Defense Medical Center, TaiwanCompletedMyocardial Infarction, AcuteTaiwan
-
National Defense Medical Center, TaiwanActive, not recruiting
-
National Defense Medical Center, TaiwanCompletedCardiovascular Diseases | Morality | Intensity CareTaiwan
-
Mayo ClinicCompletedHeart Failure | Asymptomatic Left Ventricular Systolic Dysfunction (Disorder)United States
-
Mayo ClinicCompletedAtrial FibrillationUnited States
-
National Defense Medical Center, TaiwanCompletedAtrial Fibrillation New OnsetTaiwan
-
National Defense Medical Center, TaiwanCompletedOsteoporosis | Osteoporotic FracturesTaiwan
-
Mayo ClinicEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruiting
-
Shenzhen SiBright Co., Ltd.Peking University People's Hospital; Zhongshan Ophthalmic Center, Sun Yat-sen... and other collaboratorsUnknown
-
The New Model of Care, Hail Health ClusterHealth Holding Company, Hail Health ClusterNot yet recruitingArtificial Intelegence | Diabetic Retinopathy Associated With Type 2 Diabetes Mellitus | Macular Edema Due to Type 2 Diabetes Mellitus